Antipodes-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-06
Total Holdings
102
Total Value
3193074544
Accession Number
0001652442-25-000003
Form Type
13F-HR
Manager Name
Antipodes-Partners
Data Enrichment
95% identified
97 identified5 unidentified

Holdings

102 positions • $3.2B total value
Manager:
Search and click to pin securities to the top
Page 5 of 6
Lumen Technologies, Inc.
Shares:11.4K
Value:$44.6K
% of Portfolio:0.0% ($44.6K/$3.2B)
GENERAL ELECTRIC CO
Shares:203
Value:$40.6K
% of Portfolio:0.0% ($40.6K/$3.2B)
Natera, Inc.
Shares:283
Value:$40.0K
% of Portfolio:0.0% ($40.0K/$3.2B)
Autodesk, Inc.
Shares:151
Value:$39.5K
% of Portfolio:0.0% ($39.5K/$3.2B)
Nuvalent, Inc.
Shares:540
Value:$38.3K
% of Portfolio:0.0% ($38.3K/$3.2B)
Schrodinger, Inc.
Shares:1.9K
Value:$37.1K
% of Portfolio:0.0% ($37.1K/$3.2B)
ARS Pharmaceuticals, Inc.
Shares:2.9K
Value:$37.0K
% of Portfolio:0.0% ($37.0K/$3.2B)
EXELON CORP
Shares:743
Value:$34.2K
% of Portfolio:0.0% ($34.2K/$3.2B)
DOMINION ENERGY, INC
Shares:604
Value:$33.9K
% of Portfolio:0.0% ($33.9K/$3.2B)
SI-BONE, Inc.
Shares:2.4K
Value:$33.6K
% of Portfolio:0.0% ($33.6K/$3.2B)
PROCEPT BioRobotics Corp
Shares:507
Value:$29.5K
% of Portfolio:0.0% ($29.5K/$3.2B)
GE Vernova Inc.
Shares:79
Value:$24.1K
% of Portfolio:0.0% ($24.1K/$3.2B)
Ingersoll Rand Inc.
Shares:275
Value:$22.0K
% of Portfolio:0.0% ($22.0K/$3.2B)
Oric Pharmaceuticals, Inc.
Shares:3.8K
Value:$21.3K
% of Portfolio:0.0% ($21.3K/$3.2B)
Apogee Therapeutics, Inc.
Shares:542
Value:$20.3K
% of Portfolio:0.0% ($20.3K/$3.2B)
908 Devices Inc.
Shares:4.4K
Value:$19.6K
% of Portfolio:0.0% ($19.6K/$3.2B)
Janux Therapeutics, Inc.
Shares:632
Value:$17.1K
% of Portfolio:0.0% ($17.1K/$3.2B)
Day One Biopharmaceuticals, Inc.
Shares:2.0K
Value:$16.2K
% of Portfolio:0.0% ($16.2K/$3.2B)
233051879
Shares:15.6K
Value:$15.6K
% of Portfolio:0.0% ($15.6K/$3.2B)
Fluence Energy, Inc.
Shares:2.1K
Value:$10.0K
% of Portfolio:0.0% ($10.0K/$3.2B)